Disc Medicine, Inc.
IRON
Updated: 22/09/2026, 20:40:34
Based in Watertown, Massachusetts, Disc Medicine, Inc. operates as a clinical-stage biotechnology company. Its core mission involves the discovery, development, and commercialization of novel therapeutic solutions for individuals suffering from serious hematological diseases. The company is actively constructing a pipeline of drug candidates, designed to address a variety of these conditions by precisely targeting fundamental biological mechanisms related to red blood cell biology, particularly heme biosynthesis and iron homeostasis.
No summaries found.
- Share price
- $68.65
- Market cap
- $2.64B
- Exchange
- NASDAQ
- Currency
- USD
- CEO
- John D. Quisel
- Employees
- 165
- IPO date
- 12/08/2020
- Beta
- 2.048
- Last dividend
- $0.00
- Day range
- $67.68 – $69.65
- 52-week range
- $40.00 – $99.50
- 1-day performance
- 0.23%
- 1-year performance
- 71.62%
- Current drawdown (1Y)
- -31.01%
- CIK
- 0001816736
- CUSIP
- 254604101
- ISIN
- US2546041011
- Created
- 07/12/2025, 04:46:31
- Last update
- 22/09/2026, 20:40:34
Track Disc Medicine, Inc. with an AI analyst
See which prediction-market events move IRON, how its filings map to real-world exposure, and what 12 AI strategies are doing with positions like it.
Free forever to follow AlphaBrain’s AI strategies. No card required.
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
PRNewsWire • STOCK • 14/06/2026, 11:46:00
ROSEN, LEADING INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
Newsfile Corp • STOCK • 13/06/2026, 12:13:00
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewsWire • STOCK • 12/06/2026, 17:54:00
Disc Medicine Presents Positive Clinical Updates at the 2026 European Hematology Association (EHA) Annual Meeting
GlobeNewsWire • STOCK • 12/06/2026, 10:30:00
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
Newsfile Corp • STOCK • 12/06/2026, 00:08:00
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewsWire • STOCK • 09/06/2026, 23:54:00
Disc Medicine Provides Update from FDA Type A Meeting for Bitopertin in Erythropoietic Protoporphyria
GlobeNewsWire • STOCK • 09/06/2026, 10:30:00
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
PRNewsWire • STOCK • 09/06/2026, 00:30:00
ROSEN, GLOBAL INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
Newsfile Corp • STOCK • 05/06/2026, 19:20:00
IRON Investor News: If You Have Suffered Losses in Disc Medicine, Inc. (NASDAQ: IRON), You Are Encouraged to Contact The Rosen Law Firm About Your Rights
GlobeNewsWire • STOCK • 05/06/2026, 17:25:00
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
Newsfile Corp • STOCK • 04/06/2026, 19:14:00
Rosen Law Firm Encourages Disc Medicine, Inc. Investors to Inquire About Securities Class Action Investigation - IRON
PRNewsWire • STOCK • 03/06/2026, 23:44:00